Department of Radiation Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Thorac Cancer. 2024 Oct;15(30):2156-2165. doi: 10.1111/1759-7714.15451. Epub 2024 Sep 14.
Radiotherapy is a crucial component in the holistic management of breast cancer, with approximately 60% of individuals diagnosed with breast cancer requiring this treatment. As the survival rate of individuals with breast cancer has significantly increased, there is a growing focus on the long-term well-being of patients. Proton therapy (PT) is a new and rapidly developing radiotherapy method. In comparison with conventional photon therapy, PT offers the benefits of decreased radiation toxicity and increased dosage in the designated region. This can extend patients' lifespan and enhance their overall well-being. The present analysis examines the function of PT in diminishing the harmful effects of radiation in cases of breast cancer, while also providing a brief overview of the future potential and obstacles associated with PT for breast cancer.
放射治疗是乳腺癌整体治疗的重要组成部分,大约 60%的乳腺癌患者需要接受这种治疗。随着乳腺癌患者的生存率显著提高,人们越来越关注患者的长期健康。质子治疗(PT)是一种新的、快速发展的放射治疗方法。与传统光子治疗相比,PT 具有降低辐射毒性和增加指定区域剂量的优势。这可以延长患者的寿命,提高他们的整体健康水平。本分析探讨了 PT 在减轻乳腺癌放射治疗副作用方面的作用,同时简要概述了 PT 治疗乳腺癌的未来潜力和障碍。